A new guide to inform pharmacists about the safe and effective supply of naloxone has been released by the PSA. The comprehensive guide has been produced following the TGA’s decision to broaden the scheduling of naloxone – a life-saving medicine used to for opioid overdose – to include a Schedule 3 listing. This means from
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.